The Market
The potential addressed market of the innovative inhaler devices for Asthma and COPD are the patient users that should consume a daily medicine on which is mostly steroid for prevention of attacks. The manufactured inhalers are mostly filled in with the drug by the pharmaceutical companies or certain contractors.
About 30% of the 300-400 Million of Asthma and COPD worldwide patients should consume the daily prevention drug. This is a potential sale of over 1,000 Million inhalers a year. Actually, in 2020 only 500-600 Million of inhalers annually sold to represent market size of about Euro 25 Billion.
The average annual growth rate of the market in the last 10 years was about 4-5%. The customers can be distributors and – or industrial partners while the end user is the patient.